
|Videos|December 12, 2020
Evaluating long-term safety for micro-bypass implant + phaco in PXG
Author(s)David Hutton, Alex Delaney-Gesing
Tanner Ferguson, MD, Cole Eye Institute, discusses findings from the study "Trabecular Micro-bypass Stent Implantation (iStent)" + Phacoemulsification in PXG: Six-Year Outcomes," during the virtual AAO 2020 meeting.
Advertisement
Tanner Ferguson, MD, an ophthalmology resident at the Cleveland Clinic's Cole Eye Institute, discusses findings from the study "Trabecular Micro-bypass Stent Implantation (iStent)" + Phacoemulsification in PXG: Six-Year Outcomes," during the virtual AAO 2020 meeting.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times Europe
1
Study finds artificial tear viscosity and shear-thinning behavior vary by formulation
2
IGS 2026: The expanding role of artificial intelligence in ophthalmology
3
Broadening horizons: Expanding your surgical portfolio with SMILE pro for Hyperopia
4
IGS 2026: Navigating MIGS and other modern glaucoma procedures
5




























